Psoriasis: all 1,928 studies

Page 4 of 20. Open to participants first (234), then studies with results posted, then the rest; newest registration first within each.

• Improvement of Psoriasis Patients' Adherence to Topical DrugsCompletedNCT04220554Not applicableResults posted
• Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque PsoriasisCompletedNCT04211389Phase 3Results posted
• Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque PsoriasisCompletedNCT04211363Phase 3Results posted
• A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe PsoriasisCompletedNCT04207801Phase 2Results posted
• An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South KoreaCompletedNCT04167462Phase 3Results posted
• A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)CompletedNCT04163016Phase 1Results posted
• Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body PsoriasisCompletedNCT04128007Phase 2Results posted
• A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or IxekizumabCompletedNCT04102007Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar PustulosisCompletedNCT04057937Phase 2Results posted
• Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)CompletedNCT04053387Phase 3Results posted
• Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque PsoriasisCompletedNCT04042103Phase 2Results posted
• A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar PustulosisCompletedNCT04015518Phase 2Results posted
• Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail PsoriasisCompletedNCT03991936Phase 4Results posted
• A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)CompletedNCT03988335Phase 2Results posted
• Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)CompletedNCT03983980Phase 3Results posted
• Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)CompletedNCT03956355Phase 3Results posted
• A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic PsoriasisCompletedNCT03942042Phase 4Results posted
• A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical TherapyCompletedNCT03930186Phase 3Results posted
• An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe PsoriasisCompletedNCT03924427Phase 3Results posted
• Efficacy and Safety of Tildrakizumab in the Treatment of Scalp PsoriasisCompletedNCT03897088Phase 3Results posted
• A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque PsoriasisCompletedNCT03895372Phase 2Results posted
• Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)CompletedNCT03885089Results posted
• A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque PsoriasisCompletedNCT03875508Phase 3Results posted
• A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque PsoriasisCompletedNCT03875482Phase 3Results posted
• A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic DiseasesCompletedNCT03858634Phase 2Results posted
• Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In PsoriasisCompletedNCT03850483Phase 2Results posted
• The Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis PatientsCompletedNCT03848871Phase 4Results posted
• Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque PsoriasisCompletedNCT03837743Phase 2Results posted
• A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it isTerminatedNCT03835481Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT03832738Phase 2Results posted
• A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream in Adolescent SubjectsTerminatedNCT03819218Phase 2Results posted
• A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type PsoriasisCompletedNCT03818035Phase 3Results posted
• Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis VulgarisCompletedNCT03806790Phase 3Results posted
• This Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 CreamCompletedNCT03802344Phase 3Results posted
• Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular PsoriasisCompletedNCT03782792Phase 2Results posted
• An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital PsoriasisCompletedNCT03777436Phase 3Results posted
• A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of LifeCompletedNCT03774875Phase 4Results posted
• A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)CompletedNCT03766685Phase 3Results posted
• Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque PsoriasisCompletedNCT03764475Phase 2Results posted
• A Clinical Investigation With Epaderm® CreamCompletedNCT03738163Not applicableResults posted
• Light Treatment Effectiveness (LITE) StudyCompletedNCT03726489Not applicableResults posted
• Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and EfficacyCompletedNCT03721172Phase 3Results posted
• A Study of Mirikizumab in Participants With Plaque PsoriasisCompletedNCT03718884Phase 1Results posted
• A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With PsoriasisCompletedNCT03718299Phase 4Results posted
• Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque PsoriasisCompletedNCT03706209Phase 2Results posted
• Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque PsoriasisCompletedNCT03701763Phase 3Results posted
• Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque PsoriasisCompletedNCT03668613Phase 3Results posted
• The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque PsoriasisCompletedNCT03638258Phase 2Results posted
• This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it isCompletedNCT03635099Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar PustulosisCompletedNCT03633396Phase 2Results posted
• Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human StudyCompletedNCT03626714Early Phase 1Results posted
• Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With PsoriasisCompletedNCT03624127Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Generalized Pustular PsoriasisCompletedNCT03619902Phase 2Results posted
• A Study of PRCL-02 in Moderate to Severe Chronic Plaque PsoriasisCompletedNCT03614078Phase 2Results posted
• An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque PsoriasisCompletedNCT03611751Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT03598790Phase 3Results posted
• Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of PsoriasisCompletedNCT03597620Phase 4Results posted
• Study of Efficacy and Safety of Secukinumab 2 mL Auto-injector (300 mg) in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT03589885Phase 3Results posted
• Evaluation of Add on Enstilar in Patients Using Otezla for PsoriasisCompletedNCT03587194Phase 4Results posted
• A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque PsoriasisCompletedNCT03573323Phase 4Results posted
• A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)TerminatedNCT03556202Phase 3Results posted
• Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to UstekinumabCompletedNCT03553823Phase 2Results posted
• Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)TerminatedNCT03540160Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT03536884Phase 3Results posted
• A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2)CompletedNCT03535194Phase 3Results posted
• Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of ColorCompletedNCT03506477Phase 4Results posted
• Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque PsoriasisCompletedNCT03504852Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque PsoriasisCompletedNCT03482011Phase 3Results posted
• Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque PsoriasisCompletedNCT03478787Phase 3Results posted
• Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque PsoriasisCompletedNCT03469336Phase 1Results posted
• A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 CreamCompletedNCT03462927Phase 2Results posted
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric ParticipantsActive, not recruitingNCT03451851Phase 3Results posted
• Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With ApremilastCompletedNCT03442088Phase 2Results posted
• Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque PsoriasisCompletedNCT03441789Phase 4Results posted
• Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic SyndromeCompletedNCT03440736Phase 4Results posted
• Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe PsoriasisCompletedNCT03431974Phase 2Results posted
• A Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)CompletedNCT03421197Phase 2Results posted
• A Study of LY3316531 in Healthy Participants and in Participants With PsoriasisCompletedNCT03418493Phase 1Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT03412747Phase 3Results posted
• A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT03410992Phase 3Results posted
• Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A TherapiesCompletedNCT03403036Phase 4Results posted
• Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque PsoriasisCompletedNCT03392168Phase 1/2Results posted
• An International Multicenter, Randomized, Double-blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Two Dosing Regimens of BCD-085 (JSC BIOCAD, Russia) in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT03390101Phase 3Results posted
• A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe PsoriasisCompletedNCT03384745Phase 2Results posted
• Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-IIb Trial)CompletedNCT03372811Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT03370133Phase 3Results posted
• A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque PsoriasisCompletedNCT03364309Phase 3Results posted
• Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque PsoriasisTerminatedNCT03358290Phase 2Results posted
• Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque PsoriasisCompletedNCT03343639Phase 2Results posted
• AGN-242428 in the Treatment of Plaque PsoriasisTerminatedNCT03339999Phase 2Results posted
• A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque PsoriasisCompletedNCT03331835Phase 4Results posted
• A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious PsoriasisTerminatedNCT03329885Phase 1/2Results posted
• A Clinical Trial Evaluating Efficacy and Safety of MC2-01 CreamCompletedNCT03308799Phase 3Results posted
• This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357CompletedNCT03279978Phase 1Results posted
• A Study to Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic TherapyCompletedNCT03255382Phase 3Results posted
• A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque PsoriasisCompletedNCT03230292Phase 2Results posted
• Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%TerminatedNCT03212963Phase 4Results posted
• A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque PsoriasisCompletedNCT03210961Phase 1Results posted
• The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque PsoriasisCompletedNCT03210259Phase 3Results posted
• Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06TerminatedNCT03179605Phase 2Results posted

← Psoriasis overview